WHO ICTRP trial
A single center, open-label, randomized study examining the glycemic effects of…
EUCTR2010-019161-28-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019161-28-DE |
|---|---|
| Public title | A single center, open-label, randomized study examining the glycemic effects of intra-dermal vs. subcutaneous bolus dosing of insulin lispro in patients with type 1 diabetes |
| Scientific title | A single center, open-label, randomized study examining the glycemic effects of intra-dermal vs. subcutaneous bolus dosing of insulin lispro in patients with type 1 diabetes |
| Primary sponsor | Becton, Dickinson and Company, BD Technologies |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Diabetes mellitus Type I MedDRA version: 12.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus |
| Interventions | Trade Name: Huminsulin Pharmaceutical Form: Solution for injection INN or Proposed INN: INSULIN HUMAN CAS Number: 11061-68-0 Concentration unit: U/ml unit(s)/millilitre Concentration type: equal Concentration number: 100- Trade Name… |
| Registration date | Mar 3, 2010 |
| Secondary IDs | BDT-09-ADC004 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: